Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes

Stem Cells Translational Medicine

Volumn 1, Issue 2, 2012, Pages 125-135

  Shin, Laura ^a   Peterson, Daniel A ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Autologous stem cell therapy; Diabetes; Mesenchymal stem cells

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CD31 ANTIGEN; CXCL2 CHEMOKINE; EPIDERMAL GROWTH FACTOR; GLUCOSE; HERMES ANTIGEN; INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN; TRANSCRIPTION FACTOR TBX5; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BODY WEIGHT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENGRAFTMENT; FLOW CYTOMETRY; GENE EXPRESSION; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 84876511927     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0031     Document Type: Article

References (43)

1. Bild DE, Selby JV, Sinnock P et al. Lower-extremity amputation in people with diabetes: Epidemiology and prevention. Diabetes Care 1989;12:24-31.
2. Trousdale RK, Jacobs S, Simhaee DA et al. Wound closure and metabolic parameter variability in a db/db mouse model for diabetic ulcers. J Surg Res 2009;151:100-107.
3. Stappenbeck TS, Miyoshi H. The role of stromal stem cells in tissue regeneration and wound repair. Science 2009;324:1666-1669.
4. Kuroda Y, Kitada M, Wakao S et al. Bone marrow mesenchymal cells: How do they contribute to tissue repair and are they really stem cells? Arch Immunol Ther Exp (Warsz). 2011; 59:369-378.
5. Prockop DJ, Kota DJ, Bazhanov N et al. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med 2010;14:2190-2199.
6. Volarevic V, Arsenijevic N, Lukic ML, et al. Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus. STEM CELLS 2011;29:5-10.
7. Chamberlain G, Fox J, Ashton B et al. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. STEM CELLS 2007;25:2739-2749.
8. Tolar J, Le Blanc K, Keating A et al. Concise review: Hitting the right spot with mesenchymal stromal cells. STEM CELLS 2010;28:1446-1455.
9. Liao YF, Chen LL, Zeng TS et al. Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes. Vasc Med 2010;15:279-285.
10. Jung C, Rafnsson A, Shemyakin A et al. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010;143:368-372.
11. Fiorina P, Pietramaggiori G, Scherer SS et al. The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant 2010;19:1369-1381.
12. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 1984;74:150-160.
13. Shoji T, Koyama H, Morioka T et al. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes 2006;55:2245-2255.
14. Terashi H, Izumi K, Deveci M et al. High glucose inhibits human epidermal keratinocyte proliferation for cellular studies on diabetes mellitus. Int Wound J 2005;2:298-304.
15. Lerman OZ, Galiano RD, Armour M et al. Cellular dysfunction in the diabetic fibroblast: Impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003;162:303-312.
16. Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
17. Carlson MA, Thompson JS. Wound splinting modulates granulation tissue proliferation. Matrix Biol 2004;23:243-250.
18. Galiano RD, Tepper OM, Pelo CR et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004;164:1935-1947.
19. Lin H, Xu R, Zhang Z et al. Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases. Cell Mol Immunol 2011;8:19-22.
20. Shang YC, Wang SH, Xiong F et al. Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells. Acta Pharmacol Sin 2007;28:1761-1774.
21. Michaels J 5th, Churgin SS, Blechman KM et al. db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen 2007;15: 665-670.
22. Fathke C, Wilson L, Hutter J et al. Contribution of bone marrow-derived cells to skin: Collagen deposition and wound repair. STEM CELLS 2004;22:812-822.
23. Chino T, Tamai K, Yamazaki T et al. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 2008;173:803-814.
24. Verstappen J, Katsaros C, Kuijpers-Jagtman AM et al. The recruitment of bone marrow-derived cells to skin wounds is independent of wound size. Wound Repair Regen 2011;19:260-267.
25. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 2009;4:206-216.
26. Cheng Z, Ou L, Zhou X et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008;16:571-579.
27. Urban VS, Kiss J, Kovács J et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. STEM CELLS 2008;26:244-253.
28. Pietramaggiori G, Scherer SS, Alperovich M et al. Improved cutaneous healing in diabetic mice exposed to healthy peripheral circulation. J Invest Dermatol 2009;129:2265-2274.
29. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
30. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998; 176(2A suppl):5S-10S.
31. Cohnheim J. Ueber entzündung und eiterung. Path Anat Physiol Klin Med 1867;40.
32. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A 2003;100(suppl 1): 11917-11923.
33. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008;2:313-319.
34. Mendez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466:829-834.
35. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3:301-313.
36. Lang BT, Yan Y, Dempsey RJ et al., Impaired neurogenesis in adult type-2 diabetic rats. Brain Res 2009;1258:25-33.
37. Stranahan AM, Arumugam TV, Cutler RG et al. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008; 11:309-317.
38. Gallagher KA, Liu ZJ, Xiao M et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α. J Clin Invest 2007;117:1249-1259.
39. Chalmers J, Cooper ME. UKPDS and the legacy effect. N Engl J Med 2008;359:1618-1620.
40. Pirola L, Balcerczyk A, Okabe J et al. Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol 2010;6:665-675.
41. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
42. Kong X, Zheng F, Guo LY et al. [VEGF promotes the proliferation of bone marrow derived mesenchymal stem cells through ERK1/2 signal pathway]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010;18:1292-1296.
43. Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell 2008;132:544-548.